Revenue + Forward P/E
IDEXX Laboratories, Inc. (IDXX) quarterly revenue and forward P/EForward P/E: 36.7x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$44.16B
Enterprise value
$43.84B
P/E ratio (TTM)
39.82x
P/S ratio (TTM)
9.66x
P/B ratio
28.02x
EV/Sales
9.86x
EV/EBITDA
28.13x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$4.30B
Gross profit (TTM)
$2.66B
Operating income (TTM)
$1.36B
EBITDA (TTM)
$1.47B
Net income (TTM)
$1.06B
Free cash flow (TTM)
$1.05B
Margins & returns
Gross margin
62.05%
Operating margin
31.63%
Profit margin
24.63%
Return on equity
70.87%
Return on assets
32.35%
Per-share metrics
EPS (TTM)
$13.67
Dividend yield
0.00%
Beta
1.55
Capital structure
Cash & equivalents
$180.07M
Total debt
$1.08B
Net debt
$897.14M
Shares outstanding
78.88M
Financial health
Current ratio
1.17
Debt / equity
0.67
Debt / assets
0.32
Interest coverage
35.54
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $630.07B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.32B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.22B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.68B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $44.16B | 39.82x | 9.66x | 28.13x | - |